External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation by Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man

Get full text

The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population by Monique J. C. Devillers, Johanna K. F. Pluimers, Maria C. van Hooff, Michail Doukas, Wojciech G. Polak, Robert A. de Man, Milan J. Sonneveld, Andre Boonstra, Caroline M. den Hoed

Get full text

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B by Laurens A. van Kleef, Hannah S.J. Choi, Willem P. Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld

Get full text

Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019–2021 by Elisabeth M. den Boogert, Irene K. Veldhuijzen, Ellen Generaal, Maria Prins, Milan J. Sonneveld, Adriaan J. van der Meer, Paul Zantkuijl, Birgit H.B. van Benthem, Eline L.M. Op de Coul

Get full text

The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications by Iulia Minciuna, Iulia Minciuna, Iulia Minciuna, Caroline den Hoed, Adriaan J. van der Meer, Milan J. Sonneveld, Dave Sprengers, Robert J. de Knegt, Jeroen de Jonge, Raoel Maan, Wojciech G. Polak, Sarwa Darwish Murad

Get full text

Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B by Warshan K. Katwaroe, Sylvia M. Brakenhoff, Daniël P. C. van der Spek, Robert J. de Knegt, Laurens A. van Kleef, Robert A. de Man, Adriaan J. P. van der Meer, Milan J. Sonneveld, the ICARUS Study Group

Get full text

The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 by Marleen van Dijk, Sylvia M. Brakenhoff, Cas J. Isfordink, Wei-Han Cheng, Hans Blokzijl, Greet Boland, Anthonius S. M. Dofferhoff, Bart van Hoek, Cees van Nieuwkoop, Milan J. Sonneveld, Marc van der Valk, Joost P. H. Drenth, Robert J. de Knegt

Get full text

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients by Sylvia M. Brakenhoff, Robert J. de Knegt, Margo J.H. van Campenhout, Annemiek A. van der Eijk, Willem P. Brouwer, Florian van Bömmel, André Boonstra, Bettina E. Hansen, Thomas Berg, Harry L.A. Janssen, Robert A. de Man, Milan J. Sonneveld

Get full text

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection. by Raoel Maan, Adriaan J van der Meer, Willem Pieter Brouwer, Elisabeth P C Plompen, Milan J Sonneveld, Robert Roomer, Annemiek A van der Eijk, Zwier M A Groothuismink, Bettina E Hansen, Bart J Veldt, Harry L A Janssen, Andre Boonstra, Robert J de Knegt

Get full text

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A... by Milan J. Sonneveld, Shao-Ming Chiu, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Piero Colombatto, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George N. Dalekos, Nicole S. Erler, Maurizia Brunetto, Heiner Wedemeyer, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien-Hung Chen, Benjamin Maasoumy

Get full text